Cargando…
A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985068/ https://www.ncbi.nlm.nih.gov/pubmed/29887993 http://dx.doi.org/10.1155/2018/3934296 |
_version_ | 1783328697820905472 |
---|---|
author | Bou Serhal, R. Salameh, P. Wakim, N. Issa, C. Kassem, B. Abou Jaoude, L. Saleh, N. |
author_facet | Bou Serhal, R. Salameh, P. Wakim, N. Issa, C. Kassem, B. Abou Jaoude, L. Saleh, N. |
author_sort | Bou Serhal, R. |
collection | PubMed |
description | BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. METHODOLOGY: A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. RESULTS: 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. CONCLUSION: This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients. |
format | Online Article Text |
id | pubmed-5985068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-59850682018-06-10 A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults Bou Serhal, R. Salameh, P. Wakim, N. Issa, C. Kassem, B. Abou Jaoude, L. Saleh, N. Int J Hypertens Research Article BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. METHODOLOGY: A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. RESULTS: 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. CONCLUSION: This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients. Hindawi 2018-05-20 /pmc/articles/PMC5985068/ /pubmed/29887993 http://dx.doi.org/10.1155/2018/3934296 Text en Copyright © 2018 R. Bou Serhal et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bou Serhal, R. Salameh, P. Wakim, N. Issa, C. Kassem, B. Abou Jaoude, L. Saleh, N. A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title_full | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title_fullStr | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title_full_unstemmed | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title_short | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
title_sort | new lebanese medication adherence scale: validation in lebanese hypertensive adults |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985068/ https://www.ncbi.nlm.nih.gov/pubmed/29887993 http://dx.doi.org/10.1155/2018/3934296 |
work_keys_str_mv | AT bouserhalr anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT salamehp anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT wakimn anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT issac anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT kassemb anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT aboujaoudel anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT salehn anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT bouserhalr newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT salamehp newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT wakimn newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT issac newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT kassemb newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT aboujaoudel newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT salehn newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults |